Advertisement
Screener

Beyond Air, Inc. (XAIR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.3 / 5 stars · 23/49 Roast Me

Beyond Air, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 0.00 shares.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 42.50K shares.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 2.34K shares, a 96.01% decline from fiscal 2020.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 58.66K shares, a 182.59% increase from fiscal 2019.
  • Beyond Air, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 20.76K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2023-12-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12
2023-09-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13
2023-06-3042.50K shares
10-Q · filed 2023-08-10
2021-03-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10
2.34K shares
10-K · filed 2021-06-10
2020-12-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09
20.80K shares
derived: sum of 4 quarters · filed 2021-06-10
2020-09-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12
22.78K shares
derived: sum of 4 quarters · filed 2021-06-10
2020-06-302.34K shares
10-Q · filed 2020-08-06
28.88K shares
derived: sum of 4 quarters · filed 2021-06-10
2020-03-3118.46K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10
58.66K shares
10-K · filed 2021-06-10
2019-12-311.98K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-07
2019-09-306.10K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06
2019-06-3032.12K shares
10-Q · filed 2019-08-14
2019-03-3120.76K shares
10-K · filed 2020-06-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B